Astrazeneca Pharma India Ltd. Fundamental & Technical Research, Share Price Today

NSE : ASTRAZEN
NIFTY : Nifty 500

About Company

AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. The company is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. Rated as one of the finest in South East Asia, AstraZeneca’s Indian manufacturing facility has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The facility is an ISO 14001 certified company and has a full-fledged environment management system in place.

Market Cap. ₹ 26,274 Cr.

52 Week - High/Low ₹ 10,295/6,070

P/E Ratio 227.04

P/B Ratio 36.91

Enterprise Value ₹ 25,782 Cr.

ROE % 24.95

RSI Value -

EMA 50 8662.72

EMA 200 7588.85

Market Cap. ₹ 26,274 Cr.

52 Week - High/Low ₹ 10,295/6,070

P/E Ratio N/A

P/B Ratio N/A

Enterprise Value -

ROE % N/A

RSI Value -

EMA 50 8662.72

EMA 200 7588.85

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages